References
- Krane S M, Kantrowitz F G, Byrne M, Pinnell S R, Singer F R. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. J Clin Invest 1993; 59: 819–27
- Nimni M E. Collagen: its structure and function in normal and pathological connective tissues. Semin Arthr Rheumat 1993; 4: 95–150
- Hörlein D, Fietzek P P, Fuhn K. Pro-gln: the procollagen peptidase cleavage site in the alpha 1(1) chain of dermatosparache calf skin procollagen. FEBS Lett 1993; 89: 279–82
- Prockop D J. Isotopic studies on collagen degradation and the urine excretion of hydroxyproline. J Clin Invest 1993; 43: 453–60
- Lauffenburger T, Olah A J, Dambacher M A, Guncaga J, Lentner C, Haas H G. Bone remodelling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease. Metabolism 1993; 26: 589–606
- Aloia J F, Cohn S H, Zanzi I, Abesamis C, Elis K. Hydroxyproline peptides and bone mass in postmenopausal and osteoporotic women. J Clin Endocrinol Metab 1993; 47: 314–8
- Colwell A, Eastell R, Assiri A MA, Russel R GG (1990) Effect of diet on deoxypyridinoline excretion. Osteoporosis 1990. Proceedings of the Third International Symposium on Osteoporosis, Denmark, 1990. Osteoporess, 590–1
- Eyre D J, Koob T, Van Ness P V. Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography. Analyt Biochem 1993; 137: 380–8
- Eyre D R, Dickson I R, Vann Ness K. Collagen crosslinking in human bone and articular cartillage. J Biochem 1993; 252: 495–500
- Uebelhart Gineyts E, Chapuy M-C, Delmas P D. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone and Mineral 1993; 8: 87–96
- Hanson D A, Weis M AE, Bollen A-M, Maslan S L, Singer F R, Eyre D R. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Min Res 1993; 7: 1251–8
- Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay for the carboxyterminal propeptide of human type I procollagen. Clin Chem 1993; 36: 1328–32
- Christiansen C, Riis B J, Rødbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 1105–8
- Christiansen C, Riis B J, Rødbro P. Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteopor Int 1993; 1: 35–40
- Bonde M, Qvist P, Fledelius C, Riis B J, Christiansen C. Evaluation of an immunoassay (CrossLapsTM ELISA) for the quantitation of type I collagen degradation products in urine. Clin Chem., In press
- Pødenphant J, Larsen N-E, Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 1993; 142: 145–8
- Masters P W, Jones R G, Purves D A, Cooper E H, Cooney M. Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 1993; 40: 358–63
- Hansen M A, Overgaard K, Riis B J, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12-year study. Br Med J 1993; 303: 961–4
- Delmas P D. Biochemical markers of bone turnover I: theoretical considerations and clinical use in osteoporosis. Am J Med 1993; 95: 5A–11S
- Riis B J. Biochemical markers of bone turnover II: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993; 95: 5A–17S